Eris Holdings Inc.

Company

Last mentioned: Mar 18, 2026

Stories mentioning Eris Holdings Inc. 2

pharma Neutral

ClearPoint Neuro Reports 18% Revenue Growth, Eyes $56M Target for 2026

ClearPoint Neuro (CLPT) achieved record full-year 2025 revenue of $37 million, driven by a 23% fourth-quarter surge in its Biologics and Drug Delivery segment. The company is pivoting toward a higher-growth profile through the integration of Eris Holdings and IRRAS, setting an ambitious revenue target of up to $56 million for 2026.

2 sources
medical-devices Neutral

ClearPoint Neuro Hits $37M Revenue Milestone Amid Strategic Eris Integration

ClearPoint Neuro reported a 17.8% year-over-year revenue increase for 2025, reaching $37 million, bolstered by the acquisition of Eris Holdings and growth in its biologics segment. Despite rising operational expenses and integration costs, the company demonstrated strong momentum in its neurosurgery navigation and drug delivery platforms.

2 sources